Parkman Healthcare Partners LLC Avrobio, Inc. Transaction History

Parkman Healthcare Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$10.54 - $19.3 $1.28 Million - $2.34 Million	-121,018 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$12.79 - $17.1 $506,560 - $677,262	-39,606 Reduced 24.66%	121,018 $1.69 Million
Q3 2020 Nov 13, 2020	SELL	$12.99 - $19.41 $389,297 - $581,698	-29,969 Reduced 15.72%	160,624 $2.09 Million
Q2 2020 Aug 13, 2020	SELL	$12.19 - $22.96 $1.28 Million - $2.41 Million	-105,000 Reduced 35.52%	190,593 $3.33 Million
Q1 2020 May 15, 2020	BUY	$10.08 - $27.21 $2.07 Million - $5.59 Million	205,593 Added 228.44%	295,593 $4.6 Million
Q4 2019 Feb 13, 2020	BUY	$13.05 - $21.88 $1.17 Million - $1.97 Million	90,000 New	90,000 $1.81 Million

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.